These data demonstrate that acetyl-CoA metabolism is altered in AML cells following PDH inhibition; these alterations include an increased reliance on non-PDH sources including fatty acid oxidation, ACLY and ACSS2 activity. Here, ACSS2 is linked to acute myeloid leukemia.